DETAILED NOTES ON MBL77

mutations presented The truth that, as described underneath, CLL therapy relies within the existence or absence of such mutations. The existing consensus is the fact that, aside from clonal mutations, subclonal mutations with a variant allelic frequency ranging from 5 to 10% (and thus under the edge of detection by common molecular procedures) may